Ophthotech Corp. Contracts & Agreements
104 Contracts & Agreements
- Business Finance (21 contracts)
- Business Operations (2)
- Human Resources (24)
- Intellectual Property (7)
- Mergers & Acquisitions (1)
- Real Estate (7)
- Uncategorized (42)
- Amendment No. 6 to 2019 Inducement Plan of the Registrant, dated February 23, 2023 (Filed With SEC on May 10, 2023)
- Amendment No. 5 to Non-Employee Director Compensation Policy of the Registrant, dated February 23, 2023 (Filed With SEC on May 10, 2023)
- Commercial Manufacturing and Supply Agreement, dated March 14, 2023, between the Registrant and Agilent Technologies, Inc (Filed With SEC on May 10, 2023)
- Agreement and Plan of Merger, dated as of April 28, 2023, by and among Astellas US Holding, Inc., Berry Merger Sub, Inc., IVERIC bio, Inc. and, solely as provided by Section... (Filed With SEC on May 1, 2023)
- Asset Purchase Agreement by and between Opus Genetics Inc. and IVERIC bio Gene Therapy LLC dated December 23, 2022 (Filed With SEC on March 1, 2023)
- Stock Issuance Agreement by and between Opus Genetics Inc. and IVERIC bio Gene Therapy LLC dated December 23, 2022 (Filed With SEC on March 1, 2023)
- Amendment No. 1 to 2016 Employee Stock Purchase Plan (Filed With SEC on March 1, 2023)
- Amendment No. 6 to 2019 Inducement Plan of the Registrant (Filed With SEC on March 1, 2023)
- Underwriting Agreement, dated November 30, 2022, by and among IVERIC bio, Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC, as representatives... (Filed With SEC on December 5, 2022)
- Exclusive License Agreement between the Registrant and DelSiTech Ltd., dated June 30, 2022 (Filed With SEC on July 26, 2022)
- Loan and Security Agreement between the Registrant, IVERIC bio Gene Therapy LLC, Orion Ophthalmology LLC, each of the Registrants other subsidiaries from time to time party... (Filed With SEC on July 26, 2022)
- Amendment No. 5 to the 2019 Inducement Stock Incentive Plan of the Registrant, as adopted on May 12, 2022 (Filed With SEC on July 26, 2022)
- Amendment No. 4 to Non-Employee Director Compensation Policy (Filed With SEC on May 4, 2022)
- First Amendment to The Exclusive License Agreement with Know-How by and among The University of Florida Research Foundation, Incorporated, The Trustees of the University of... (Filed With SEC on February 24, 2022)
- Offer Letter between the Registrant and Christopher Simms dated June 16, 2021 (Filed With SEC on February 24, 2022)
- Letter Agreement between the Registrant and Christopher Simms dated June 16, 2021 (Filed With SEC on February 24, 2022)
- Offer Letter between the Registrant and Tony Gibney dated November 19, 2021 (Filed With SEC on February 24, 2022)
- Letter Agreement between the Registrant and Tony Gibney dated November 10, 2021 (Filed With SEC on February 24, 2022)
- Offer of Employment between the Registrant and Christopher Simms, dated June 16, 2021 (Filed With SEC on November 9, 2021)
- Letter Agreement between the Registrant and Christopher Simms, dated June 16, 2021 (Filed With SEC on November 9, 2021)
- Amendment No. 3 to the 2019 Inducement Stock Incentive Plan of the Registrant (Filed With SEC on November 9, 2021)
- Letter Agreement between the Registrant and Glenn P. Sblendorio, dated November 3, 2021 (Filed With SEC on November 9, 2021)
- Underwriting Agreement, dated October 21, 2021, by and among IVERIC bio, Inc. and Morgan Stanley & Co. LLC, Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated and... (Filed With SEC on October 25, 2021)
- Amendment No. 2 to Master Sponsored Research Agreement, dated May 18, 2021, between Trustees of the University of Pennsylvania and the Registrant (Filed With SEC on August 4, 2021)
- Underwriting Agreement, dated July 12, 2021, by and among IVERIC bio, Inc. and Cowen and Company, LLC, Credit Suisse Securities (USA) LLC and Stifel, Nicolaus & Company,... (Filed With SEC on July 14, 2021)
- Amendment No. 2 to the Non-Employee Director Compensation Policy of the Registrant (Filed With SEC on May 5, 2021)
- Retirement and Consulting Agreement, dated April 4, 2021, by and between IVERIC bio, Inc. and David R. Guyer, M.D (Filed With SEC on April 5, 2021)
- Amendment No. 2 to 2019 Inducement Stock Incentive Plan of the Registrant (Filed With SEC on March 4, 2021)
- Offer Letter between the Registrant and Pravin U. Dugel, dated March 11, 2020 (Filed With SEC on August 6, 2020)
- Severance Agreement between the Registrant and Pravin U. Dugel, dated March 11, 2020 (Filed With SEC on August 6, 2020)
- Underwriting Agreement, dated June 17, 2020, by and among IVERIC bio, Inc. and Cowen and Company, LLC and Credit Suisse Securities (USA) LLC, as representatives of the... (Filed With SEC on June 19, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on June 19, 2020)
- Stock Purchase Agreement, dated as of June 17, 2020, by and among IVERIC bio, Inc. and certain purchasers named therein (Filed With SEC on June 19, 2020)
- Amendment No. 1 to 2019 Inducement Stock Incentive Plan of the Registrant (Filed With SEC on May 7, 2020)
- Amendment No. 1 to Exclusive License Agreement with Know-How, by and among Trustees of the University of Pennsylvania, University of Florida Research Foundation, Incorporated and... (Filed With SEC on May 7, 2020)
- Letter agreement between One Penn Plaza LLC and Registrant, dated April 6, 2020 (Filed With SEC on May 7, 2020)
- Description of Registered Securities of the Registrant (Filed With SEC on February 27, 2020)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on February 27, 2020)
- Letter Agreement between the Registrant and David F. Carroll, dated December 11, 2019 (Filed With SEC on February 27, 2020)
- Letter Agreement between the Registrant and Keith Westby, dated December 11, 2019 (Filed With SEC on February 27, 2020)
- Underwriting Agreement, dated December 6, 2019, by and between IVERIC bio, Inc. and Cowen and Company, LLC, as representative of the underwriters named therein (Filed With SEC on December 10, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on December 10, 2019)
- Exclusive License Agreement, by and between the University of Massachusetts and Registrant, dated July 22, 2019 (Filed With SEC on November 12, 2019)
- Amendment No. 1 to Master Sponsored Research Agreement, by and between The Trustees of the University of Pennsylvania and Registrant, dated October 1, 2019 (Filed With SEC on November 12, 2019)
- Amendment No. 1 to Master Sponsored Research Agreement, by and between The Trustees of the University of Pennsylvania and Registrant, dated October 1, 2019 (Filed With SEC on November 12, 2019)
- Exclusive License Agreement with Know-How, by and among The Trustees of the University of Pennsylvania, The University of Florida Research Foundation, Incorporated, acting as a... (Filed With SEC on August 1, 2019)
- Master Sponsored Research Agreement, by and between The Trustees of the University of Pennsylvania and Registrant, dated October 30, 2018 (Filed With SEC on August 1, 2019)
- Non-Employee Director Compensation Policy of the Registrant (Filed With SEC on August 1, 2019)
- Exclusive License Agreement with Know-How by and among The University of Florida Research Foundation, Incorporated, The Trustees of the University of Pennsylvania and the... (Filed With SEC on August 1, 2018)
- Master Sponsored Research Agreement by and between The Trustees of the University of Pennsylvania and the Registrant dated June 6, 2018 (Filed With SEC on August 1, 2018)
- Sixth Amendment of Lease, dated as of June 29, 2018, between the Registrant and One Penn Plaza LLC (Filed With SEC on August 1, 2018)
- Letter agreement by and between the Registrant and David R. Guyer dated May 12, 2018 (Filed With SEC on August 1, 2018)
- Letter agreement by and between the Registrant and David R. Guyer dated May 24, 2018 (Filed With SEC on August 1, 2018)
- Fifth Amendment of Lease, dated as of October 1, 2017, between the Registrant and One Penn Plaza LLC (Filed With SEC on March 5, 2018)
- Separation and Release Agreement between the Registrant and Barbara A. Wood, dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Letter Agreement between the Registrant and Novartis Pharma AG, dated July 3, 2017 (Filed With SEC on November 8, 2017)
- One Penn Plaza, Suite 19th Floor New York, NY 10119 ###-###-#### (Filed With SEC on August 2, 2017)
- One Penn Plaza, Suite 19th Floor New York, NY 10119 ###-###-#### (Filed With SEC on August 2, 2017)
- One Penn Plaza, Suite 19th Floor New York, NY 10119 ###-###-#### (Filed With SEC on August 2, 2017)
- One Penn Plaza, Suite 19th Floor New York, NY 10119 ###-###-#### (Filed With SEC on May 3, 2017)
- SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on February 28, 2017)
- OPHTHOTECH CORPORATION CONSULTING AGREEMENT (Filed With SEC on February 28, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on February 28, 2017)
- ADDENDUM TO OFFICE LEASE AGREEMENT Between PSN PARTNERS, L.P. a New Jersey Limited Partnership LANDLORD And OPHTHOTECH CORPORATION TENANT (Filed With SEC on August 5, 2016)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 5, 2016)
- One Penn Plaza 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 9, 2016)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 9, 2016)
- One Penn Plaza 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on February 26, 2016)
- One Penn Plaza 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on February 26, 2016)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on February 26, 2016)
- OPHTHOTECH CORPORATION Nonstatutory Stock Option Agreement (Filed With SEC on February 26, 2016)
- One Penn Plaza, 35thFloor, New York, NY 10119 Phone: 212 ###-###-#### Fax: 212 ###-###-#### (Filed With SEC on February 26, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT NO. 1 TO THE CLINICAL MANUFACTURING... (Filed With SEC on November 5, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 5, 2015)
- AMENDMENT NO. 1 TO 2013 STOCK INCENTIVE PLAN OF OPHTHOTECH CORPORATION (Filed With SEC on August 10, 2015)
- SUBLEASE AGREEMENT (Filed With SEC on August 10, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 11, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 11, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 11, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 11, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 11, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on May 11, 2015)
- OPHTHOTECH CORPORATION 2013 STOCK INCENTIVE PLAN (Filed With SEC on March 2, 2015)
- OPHTHOTECH CORPORATION Restricted Stock Unit Agreement 2013 Stock Incentive Plan NOTICE OF GRANT (Filed With SEC on March 2, 2015)
- One Penn Plaza, Suite 19thFloor New York, NY 10119 ###-###-#### (Filed With SEC on November 12, 2014)
- OPHTHOTECH CORPORATION Nonstatutory Stock Option Agreement (Filed With SEC on November 12, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CLINICAL MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 6, 2014)
- [] Shares OPHTHOTECH CORPORATION COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on February 10, 2014)
- [] Shares OPHTHOTECH CORPORATION COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on September 9, 2013)
- OPHTHOTECH CORPORATION 2013 STOCK INCENTIVE PLAN (Filed With SEC on September 9, 2013)
- OPHTHOTECH CORPORATION Incentive Stock Option Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on September 9, 2013)
- OPHTHOTECH CORPORATION Nonstatutory Stock Option Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on September 9, 2013)
- LEASE between ONE PENN PLAZA LLC, Landlord, and OPHTHOTECH CORPORATION, Tenant. One Penn Plaza New York, New York 10119 as of September 30, 2007 TABLE OF CONTENTS (Filed With SEC on September 9, 2013)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions. LICENSE, MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on September 9, 2013)
- OPHTHOTECH CORPORATION One PennPlaza 35th Floor New York, NY 10119 ###-###-#### (Filed With SEC on September 9, 2013)
- SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on September 9, 2013)
- OPHTHOTECH CORPORATION One PennPlaza 35th Floor New York, NY 10119 ###-###-#### (Filed With SEC on September 9, 2013)
- TABLE OF CONTENTS (Filed With SEC on September 9, 2013)
- THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on August 15, 2013)
- OPHTHOTECH CORPORATION AMENDED AND RESTATED 2007 STOCK INCENTIVE PLAN (Filed With SEC on August 15, 2013)
- OPHTHOTECH CORPORATION Incentive Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on August 15, 2013)
- OPHTHOTECH CORPORATION Nonstatutory Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on August 15, 2013)
- LEASE between ONE PENN PLAZA LLC, Landlord, and OPHTHOTECH CORPORATION, Tenant. One Penn Plaza New York, New York 10119 as of September 30, 2007 TABLE OF CONTENTS (Filed With SEC on August 15, 2013)
- SHORT FORM LEASE Between VAUGHN PRINCETON ASSOCIATES L.L.C. as Landlord, and OPHTHOTECH CORP. as Tenant Building: 5 Vaughn Drive, Princeton, New Jersey (Filed With SEC on August 15, 2013)